Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. IDEXX Laboratories, Inc.

12.2% sales growth and 154.61% return on equity

IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide.

IDEXX Laboratories, Inc.’s sales growth this year is expected to be 10.8% and 10.6% for next year.

Year-on-year quarterly revenue growth grew by 19.2%, now sitting on 2.59B for the twelve trailing months.

IDEXX Laboratories, Inc.’s sales growth for the next quarter is 12.2%. The company’s growth estimates for the current quarter and the next is 32.7% and 18.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 154.61%.

IDEXX Laboratories, Inc.’s Stock Yearly Top and Bottom Value

IDEXX Laboratories, Inc.’s stock is valued at $499.15 at 10:22 EST, under its 52-week high of $499.62 and way higher than its 52-week low of $168.65.

IDEXX Laboratories, Inc.’s Moving Average

IDEXX Laboratories, Inc.’s value is above its 50-day moving average of $460.32 and way above its 200-day moving average of $393.57.

2. EPAM Systems, Inc.

13.9% sales growth and 18.86% return on equity

EPAM Systems, Inc. provides digital platform engineering and software development services in North America, Europe, Armenia, Belarus, Kazakhstan, Russia, Ukraine, Asia, and Australia.

EPAM Systems, Inc.’s sales growth this year is expected to be 15.1% and 21.6% for next year.

Year-on-year quarterly revenue growth grew by 10.9%, now sitting on 2.57B for the twelve trailing months.

EPAM Systems, Inc.’s sales growth for the next quarter is 13.9%. The company’s growth estimates for the ongoing quarter and the next is 13.2% and 17.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.86%.

EPAM Systems, Inc.’s Stock Yearly Top and Bottom Value

EPAM Systems, Inc.’s stock is valued at $346.53 at 10:22 EST, under its 52-week high of $359.39 and way higher than its 52-week low of $151.97.

EPAM Systems, Inc.’s Moving Average

EPAM Systems, Inc.’s value is higher than its 50-day moving average of $326.99 and way above its 200-day moving average of $302.82.

3. BioDelivery Sciences International, Inc.

14.1% sales growth and 18.1% return on equity

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products in the United States and internationally.

BioDelivery Sciences International, Inc.’s sales growth this year is expected to be 37.3% and 25.9% for next year.

Year-on-year quarterly revenue growth grew by 30.1%, now sitting on 145.94M for the twelve trailing months.

BioDelivery Sciences International, Inc.’s sales growth for the next quarter is 14.1%. The company’s growth estimates for the present quarter and the next is 600% and 60%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.1%.

BioDelivery Sciences International, Inc.’s Stock Yearly Top and Bottom Value

BioDelivery Sciences International, Inc.’s stock is valued at $4.48 at 10:22 EST, way below its 52-week high of $7.21 and way above its 52-week low of $2.85.

BioDelivery Sciences International, Inc.’s Moving Average

BioDelivery Sciences International, Inc.’s value is way above its 50-day moving average of $3.93 and higher than its 200-day moving average of $4.11.

4. Perdoceo Education Corporation

5.6% sales growth and 27.03% return on equity

Perdoceo Education Corporation operates colleges, institutions, and universities that provide education to student population in various career-oriented disciplines through online, campus based, and blended learning programs in the United States.

Perdoceo Education Corporation’s sales growth this year is expected to be 9.6% and 2.9% for next year.

Year-on-year quarterly revenue growth grew by 9.1%, now sitting on 674.61M for the twelve trailing months.

Perdoceo Education Corporation’s sales growth for the next quarter is 5.6%. The company’s growth estimates for the ongoing quarter and the next is 3% and 9.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.03%.

Perdoceo Education Corporation’s Stock Yearly Top and Bottom Value

Perdoceo Education Corporation’s stock is valued at $13.10 at 10:22 EST, way below its 52-week high of $19.85 and way above its 52-week low of $7.11.

Perdoceo Education Corporation’s Moving Average

Perdoceo Education Corporation’s worth is higher than its 50-day moving average of $11.98 and under its 200-day moving average of $13.57.

5. Charles Schwab Corporation

49.2% sales growth and 11.45% return on equity

The Charles Schwab Corporation, through its subsidiaries, provides wealth management, securities brokerage, banking, asset management, custody, and financial advisory services.

Charles Schwab Corporation’s sales growth this year is expected to be 7.9% and 33% for next year.

Year-on-year quarterly revenue growth declined by 9.7%, now sitting on 10.12B for the twelve trailing months.

Charles Schwab Corporation’s sales growth for the next quarter is 49.2%. The company’s growth estimates for the ongoing quarter and the next is 9.7% and 1.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.45%.

Charles Schwab Corporation’s Stock Yearly Top and Bottom Value

Charles Schwab Corporation’s stock is valued at $51.98 at 10:22 EST, below its 52-week high of $52.22 and way above its 52-week low of $28.00.

Charles Schwab Corporation’s Moving Average

Charles Schwab Corporation’s worth is above its 50-day moving average of $47.93 and way above its 200-day moving average of $38.88.

6. USANA Health Sciences, Inc.

7.5% sales growth and 32.92% return on equity

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products.

USANA Health Sciences, Inc.’s sales growth this year is expected to be 5.2% and 6.6% for next year.

Year-on-year quarterly revenue growth grew by 14.5%, now sitting on 1.1B for the twelve trailing months.

USANA Health Sciences, Inc.’s sales growth for the next quarter is 7.5%. The company’s growth estimates for the present quarter and the next is a negative 0% and 12.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.92%.

USANA Health Sciences, Inc.’s Stock Yearly Top and Bottom Value

USANA Health Sciences, Inc.’s stock is valued at $77.84 at 10:22 EST, way below its 52-week high of $92.26 and way above its 52-week low of $43.01.

USANA Health Sciences, Inc.’s Moving Average

USANA Health Sciences, Inc.’s value is higher than its 50-day moving average of $76.47 and below its 200-day moving average of $78.76.

7. BancFirst Corporation

7% sales growth and 9.86% return on equity

BancFirst Corporation operates as the bank holding company for BancFirst that provides a range of commercial banking services to retail customers, and small to medium-sized businesses.

BancFirst Corporation’s sales growth this year is anticipated to be 5.2% and a negative 1.7% for next year.

Year-on-year quarterly revenue growth declined by 12.8%, now sitting on 379.33M for the twelve trailing months.

BancFirst Corporation’s sales growth for the next quarter is 7%. The company’s growth estimates for the present quarter and the next is a negative 32.1% and 42.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.86%.

BancFirst Corporation’s Stock Yearly Top and Bottom Value

BancFirst Corporation’s stock is valued at $55.00 at 10:22 EST, way below its 52-week high of $63.96 and way above its 52-week low of $26.00.

BancFirst Corporation’s Moving Average

BancFirst Corporation’s value is above its 50-day moving average of $54.41 and way above its 200-day moving average of $45.20.

8. Thor Industries, Inc.

63% sales growth and 12.55% return on equity

Thor Industries, Inc. designs, manufactures, and sells recreational vehicles (RVs), and related parts and accessories in the United States, Canada, and Europe.

Thor Industries, Inc.’s sales growth this year is anticipated to be 28.8% and 3.8% for next year.

Year-on-year quarterly revenue growth grew by 17.5%, now sitting on 8.55B for the twelve trailing months.

Thor Industries, Inc.’s sales growth for the next quarter is 63%. The company’s growth estimates for the ongoing quarter and the next is 130.3% and 316.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.55%.

Thor Industries, Inc.’s Stock Yearly Top and Bottom Value

Thor Industries, Inc.’s stock is valued at $95.63 at 10:22 EST, way below its 52-week high of $121.33 and way higher than its 52-week low of $32.30.

Thor Industries, Inc.’s Moving Average

Thor Industries, Inc.’s worth is higher than its 50-day moving average of $92.26 and below its 200-day moving average of $100.10.

LEAVE A REPLY

Please enter your comment!
Please enter your name here